PBPK models for the prediction of in vivo performance of oral dosage forms
2013 · European Journal of Pharmaceutical Sciences · 313 citations
https://doi.org/10.1016/j.ejps.2013.09.008
M
Martin Bergstrand
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
63
Papers
3.1K
Citations
18
h-index
30
i10-index
Martin Bergstrand is an academic researcher from Prometheus (United States). The author has contributed to research in topics: Statistical Methods in Clinical Trials & Pharmaceutical studies and practices & Drug Solubulity and Delivery Systems. The author has an h-index of 18, co-authored 54 publications.
ORCID: 0000-0002-0295-1227Papers by this author
worksA strategy for residual error modeling incorporating scedasticity of variance and distribution shape
2015 · Journal of Pharmacokinetics and Pharmacodynamics · 26 citations
https://doi.org/10.1007/s10928-015-9460-y
Population pharmacokinetic and pharmacodynamic properties of artesunate in patients with artemisinin sensitive and resistant infections in Southern Myanmar
2018 · Malaria Journal · 17 citations
https://doi.org/10.1186/s12936-018-2278-5
Pharmacokinetic modeling and simulation support for age‐ and weight‐adjusted dosing of dabigatran etexilate in children with venous thromboembolism
2021 · Journal of Thrombosis and Haemostasis · 17 citations
https://doi.org/10.1111/jth.15277
In Vitro and In Vivo Modeling of Hydroxypropyl Methylcellulose (HPMC) Matrix Tablet Erosion Under Fasting and Postprandial Status
2017 · Pharmaceutical Research · 15 citations
https://doi.org/10.1007/s11095-017-2113-7
Population Pharmacokinetic and Pharmacodynamic Modeling of Artemisinin Resistance in Southeast Asia
2017 · The AAPS Journal · 14 citations
https://doi.org/10.1208/s12248-017-0141-1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat